These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11977820)

  • 1. Spasm in MS.
    Spencer S
    Nurs Stand; 2001 Oct 10-16; 16(4):24. PubMed ID: 11977820
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a 4-week period of unloaded leg cycling exercise on spasticity in multiple sclerosis.
    Sosnoff J; Motl RW; Snook EM; Wynn D
    NeuroRehabilitation; 2009; 24(4):327-31. PubMed ID: 19597270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Our experts explain... Emin concept - not a remedy].
    Friedhoff M; Jacobs G
    Pflege Z; 2015 Jan; 68(1):12-6. PubMed ID: 25845110
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of symptoms associated with spasticity in patients with multiple sclerosis].
    Fernández-Pablos MA; Costa-Frossard L; García-Hernández C; García-Montes I; Escutia-Roig M;
    Enferm Clin; 2016; 26(6):367-373. PubMed ID: 27492746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-medicinal treatments of spasticity in multiple sclerosis].
    Mailhan L; Papeix C
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S57-61. PubMed ID: 22721366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spasticity and everyday life in multiple sclerosis].
    Donzé C; De Sèze J
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S51-6. PubMed ID: 22721365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conclusion].
    Bensmail D
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S69. PubMed ID: 22721368
    [No Abstract]   [Full Text] [Related]  

  • 8. Non pharmacological interventions for spasticity in multiple sclerosis.
    Amatya B; Khan F; La Mantia L; Demetrios M; Wade DT
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009974. PubMed ID: 23450612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology and clinical assessment of spasticity in multiple sclerosis].
    Bensmail D; Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S45-50. PubMed ID: 22721364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental treatment stroke rehabilitation: a critique and extension for neuroscience nursing practice.
    Seneviratne C; Reimer M
    Axone; 2004 Dec; 26(2):13-20. PubMed ID: 15663315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study.
    Negahban H; Rezaie S; Goharpey S
    Clin Rehabil; 2013 Dec; 27(12):1126-36. PubMed ID: 23828184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spasticity in multiple sclerosis.
    Barnes MP; Kent RM; Semlyen JK; McMullen KM
    Neurorehabil Neural Repair; 2003 Mar; 17(1):66-70. PubMed ID: 12645447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FES cycling reduces spastic muscle tone in a patient with multiple sclerosis.
    Krause P; Szecsi J; Straube A
    NeuroRehabilitation; 2007; 22(4):335-7. PubMed ID: 17971625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spasticity: a common symptom of multiple sclerosis.
    Currie R
    Nurs Stand; 2001 May 2-8; 15(33):47-52; quiz 54-5. PubMed ID: 12216268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into multiple sclerosis and advances in multiple sclerosis spasticity management.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):1-2. PubMed ID: 24289835
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous intrathecal baclofen infusions. An introduction and overview.
    Kamensek J
    Axone; 1999 Mar; 20(3):67-72. PubMed ID: 10401268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Editorial. Spasticity in multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S35. PubMed ID: 22721362
    [No Abstract]   [Full Text] [Related]  

  • 19. What is new in MS spasticity research? Poster session highlights.
    Kappos L; Fazekas F
    Neurodegener Dis Manag; 2015; 5(6 Suppl):27-30. PubMed ID: 26611269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of MS spasticity.
    Pozzilli C
    Eur Neurol; 2014; 71 Suppl 1():1-3. PubMed ID: 24457845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.